Dermatitis. Acute radiodermatitis
Conditions
Interventions
Intervention 1: Intervention group: Women with breast cancer in the age range of 30 to 70 years who underwent surgery (lumpectomy) and chemotherapy and after 3 to 4 weeks of chemotherapy, referred to
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: women with breast cancer who are between 30 to 70 years old they underwent breast lumpectomy surgery after 3-4 weeks of surgury, they came for radiotherapy
Exclusion criteria
Exclusion criteria: patients who have an underlying disease and a history of skin inflammation patients who are in stage 4 or are undergoing radiotherapy for palliation patients with Modified Radical Mastectomy must not be included in the study. Patients with a history of severe allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of radiotherapy-induced dermatitis according to RTOG classification. Timepoint: The severity of radiation dermatitis is evaluated once a week from the time of entering the study until the completion of the radiotherapy treatment. Method of measurement: Based on the criteria of Radiation Therapy Oncology Group. | — |
Secondary
| Measure | Time frame |
|---|---|
| The time which symptoms of dermatitis develop. Timepoint: Once a week from the beginning of the study to the end of the radiotherapy duration. Method of measurement: We record the time when the symptoms of dermatitis developed in the weekly examination according to the opinion of the specialist who evaluates the patients.;Severity of patients' pain. Timepoint: Once a week from the beginning of the study to the end of the radiotherapy duration. Method of measurement: We record the change in pain intensity in the weekly examination according to the opinion of the specialist who evaluates the patients. The pain intensity of the patients is measured using the Visual Analogue Scale index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Ramezanpour
Babol University of Medical Sciences
Outcome results
None listed